🇨🇦·15h agoIndustry
Le Québec est la première province à inscrire Pr OKEDI MD (suspension injectable à libération prolongée de rispéridone) sur la liste des médicaments remboursés par le régime public pour le traitement de la schizophrénie
Publisher
B
Bausch Health (IR News)
Canada
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Bausch Health (IR News)
- Region
- Canada
- Scope
- Industry
- Published
- July 6, 2026
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on ir.bauschhealth.com
Leave the platform to read the original full article on the publisher site.
Source: Bausch Health (IR News)
Scope: Industry
Related coverage